[Effects of calcium gluconate and calcium chloride on cardiocirculatory parameters in man (author's transl)]

Der Anaesthesist
|November 1, 1978
PubMed

Insights

Calcium chloride and calcium gluconate both impact hemodynamics and myocardial oxygen consumption in heart patients. Calcium chloride demonstrated more pronounced positive inotropic effects, suggesting its greater utility in emergencies.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Pharmacology

Background:

  • Patients with heart disease often require cardiovascular surgery.
  • Intraoperative management of hemodynamics is critical.
  • Calcium is essential for myocardial contractility.

Purpose of the Study:

  • To compare the effects of calcium gluconate and calcium chloride on hemodynamics, inotropy, and myocardial oxygen consumption.
  • To evaluate the efficacy of these calcium preparations during and after cardiosurgical procedures.
  • To determine the preferred calcium agent for emergency situations in cardiac surgery.

Main Methods:

  • A study involving 44 patients with New York Heart Association (NYHA) functional class II-IV heart disease undergoing cardiosurgery.
  • Intravenous administration of calcium gluconate (10 ml 10%) and calcium chloride (5.5%) during and immediately after surgery.
  • Monitoring of hemodynamic parameters, inotropic state, and myocardial oxygen consumption.

Main Results:

  • Both calcium gluconate and calcium chloride significantly increased blood pressure, left ventricular pressure, total systemic resistance, cardiac index, stroke index, peak dp/dt, and myocardial oxygen consumption.
  • Arterial perfusion pressure also increased during extracorporeal circulation with both agents.
  • Calcium chloride exhibited more pronounced positive inotropic effects compared to calcium gluconate.

Conclusions:

  • Both calcium gluconate and calcium chloride can improve hemodynamic parameters and myocardial oxygen consumption in cardiac surgery patients.
  • Calcium chloride appears to be more advantageous than calcium gluconate in emergency settings during anesthesia or resuscitation due to its stronger inotropic effects.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...